India  

Coronavirus vaccine: Pfizer CEO discusses COVID-19 vaccine by end of November possibly

Upworthy Sunday, 18 October 2020 ()
Pfizer CEO Albert Bourla announced the company’s Covid-19 vaccine could be available by late November. Yahoo Finance’s Anjalee Khemlani...
0
shares
ShareTweetSavePostSend
 
Video Credit: KTNV Channel 13 Las Vegas - Published
News video: Pfizer enrolls 12 year olds in coronavirus vaccine trials

Pfizer enrolls 12 year olds in coronavirus vaccine trials 00:45

Pfizer is the first company to say it will start enrolling kids as young as 12 in its U.S. coronavirus vaccine trial. It says it received permission from the FDA this month.

You Might Like


Related videos from verified sources

The trials, tribulations and timeline of a COVID-19 vaccine | Jerome Kim [Video]

The trials, tribulations and timeline of a COVID-19 vaccine | Jerome Kim

Developing a vaccine usually takes five to 10 years, costs about a billion dollars and has a failure rate of 93 percent. Under the pressure of the coronavirus pandemic, scientists are being asked to..

Credit: TED     Duration: 23:32Published
Dr. Fauci says findings on potential COVID-19 vaccine expected by December [Video]

Dr. Fauci says findings on potential COVID-19 vaccine expected by December

Dr. Fauci says findings on potential COVID-19 vaccine expected by December

Credit: nypost     Duration: 00:57Published
AstraZeneca Covid-19 Vaccine Trial Showing Promising Results [Video]

AstraZeneca Covid-19 Vaccine Trial Showing Promising Results

AstraZeneca's Covid-19 vaccine trial has shown promise producing antibodies in adult and elderly patients, a sign that a viable vaccine could be ready by year-end.

Credit: The Street     Duration: 02:03Published

Tweets about this